Methotrexate and misoprostol for early abortion in adolescent women

Mitchell D Creinin, E. Wiebe, M. Gold

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Study Objective: Investigate the potential effectiveness, side effects, and acceptability of medical abortion in female adolescents. Design: Multicenter cohort study. Setting: Magee-Womens Hospital (Pittsburgh, PA) and University of British Columbia (Vancouver, BC, Canada). Participants: Twenty-five pregnant adolescents less than 18 years old up to 49 days' gestation. Interventions: Methotrexate, 50 mg/m2 intramuscularly, followed 5 to 6 days later by misoprostol, 800 μg vaginally, self-administered at home. Misoprostol administration was repeated by a doctor if abortion did not occur within 1 or 2 days. Acceptability was assessed before methotrexate injection and at follow-up 5 weeks later. Main Outcome Measures: Successful abortion (complete abortion without requiring a surgical procedure), immediate success (abortion within 24 hours of initial or repeat misoprostol administration), and acceptability. Results: Complete abortion occurred in 24 of 25 (96%; 95% confidence interval [CI], 88%-100%) subjects. Immediate success abortion occurred in 23 (92%; 95% CI, 81%-100%) of these young women; the remaining subject who aborted did so on study day 10. The single failure was an incomplete abortion. Of the 23 participants who completed the follow-up acceptability evaluation, 4 (17%) believed that the process was a negative experience; 83% of participants would choose this same method again for a future abortion if needed and would recommend this method to a friend. Those who would not try this method again were without support of another individual at the time of the abortion. Conclusions: This medical abortion regimen is effective in adolescents. The overall acceptability in adolescents is similar to that reported for women 18 years of age or older. To minimize the likelihood of a negative experience with this abortion method in adolescents, home support for these patients should be evaluated during pretreatment counseling.

Original languageEnglish (US)
Pages (from-to)71-77
Number of pages7
JournalJournal of Pediatric and Adolescent Gynecology
Volume12
Issue number2
DOIs
StatePublished - May 1999
Externally publishedYes

Fingerprint

Misoprostol
Methotrexate
Incomplete Abortion
Confidence Intervals
British Columbia
Multicenter Studies
Canada
Counseling
Cohort Studies
Outcome Assessment (Health Care)
Pregnancy
Injections

Keywords

  • Abortion
  • Abortion, medical
  • Methotrexate
  • Misoprostol
  • Prostaglandins

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Methotrexate and misoprostol for early abortion in adolescent women. / Creinin, Mitchell D; Wiebe, E.; Gold, M.

In: Journal of Pediatric and Adolescent Gynecology, Vol. 12, No. 2, 05.1999, p. 71-77.

Research output: Contribution to journalArticle

@article{b35d408f7b8c464298edf6b3892839eb,
title = "Methotrexate and misoprostol for early abortion in adolescent women",
abstract = "Study Objective: Investigate the potential effectiveness, side effects, and acceptability of medical abortion in female adolescents. Design: Multicenter cohort study. Setting: Magee-Womens Hospital (Pittsburgh, PA) and University of British Columbia (Vancouver, BC, Canada). Participants: Twenty-five pregnant adolescents less than 18 years old up to 49 days' gestation. Interventions: Methotrexate, 50 mg/m2 intramuscularly, followed 5 to 6 days later by misoprostol, 800 μg vaginally, self-administered at home. Misoprostol administration was repeated by a doctor if abortion did not occur within 1 or 2 days. Acceptability was assessed before methotrexate injection and at follow-up 5 weeks later. Main Outcome Measures: Successful abortion (complete abortion without requiring a surgical procedure), immediate success (abortion within 24 hours of initial or repeat misoprostol administration), and acceptability. Results: Complete abortion occurred in 24 of 25 (96{\%}; 95{\%} confidence interval [CI], 88{\%}-100{\%}) subjects. Immediate success abortion occurred in 23 (92{\%}; 95{\%} CI, 81{\%}-100{\%}) of these young women; the remaining subject who aborted did so on study day 10. The single failure was an incomplete abortion. Of the 23 participants who completed the follow-up acceptability evaluation, 4 (17{\%}) believed that the process was a negative experience; 83{\%} of participants would choose this same method again for a future abortion if needed and would recommend this method to a friend. Those who would not try this method again were without support of another individual at the time of the abortion. Conclusions: This medical abortion regimen is effective in adolescents. The overall acceptability in adolescents is similar to that reported for women 18 years of age or older. To minimize the likelihood of a negative experience with this abortion method in adolescents, home support for these patients should be evaluated during pretreatment counseling.",
keywords = "Abortion, Abortion, medical, Methotrexate, Misoprostol, Prostaglandins",
author = "Creinin, {Mitchell D} and E. Wiebe and M. Gold",
year = "1999",
month = "5",
doi = "10.1016/S1083-3188(00)86630-9",
language = "English (US)",
volume = "12",
pages = "71--77",
journal = "Journal of Pediatric and Adolescent Gynecology",
issn = "1083-3188",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Methotrexate and misoprostol for early abortion in adolescent women

AU - Creinin, Mitchell D

AU - Wiebe, E.

AU - Gold, M.

PY - 1999/5

Y1 - 1999/5

N2 - Study Objective: Investigate the potential effectiveness, side effects, and acceptability of medical abortion in female adolescents. Design: Multicenter cohort study. Setting: Magee-Womens Hospital (Pittsburgh, PA) and University of British Columbia (Vancouver, BC, Canada). Participants: Twenty-five pregnant adolescents less than 18 years old up to 49 days' gestation. Interventions: Methotrexate, 50 mg/m2 intramuscularly, followed 5 to 6 days later by misoprostol, 800 μg vaginally, self-administered at home. Misoprostol administration was repeated by a doctor if abortion did not occur within 1 or 2 days. Acceptability was assessed before methotrexate injection and at follow-up 5 weeks later. Main Outcome Measures: Successful abortion (complete abortion without requiring a surgical procedure), immediate success (abortion within 24 hours of initial or repeat misoprostol administration), and acceptability. Results: Complete abortion occurred in 24 of 25 (96%; 95% confidence interval [CI], 88%-100%) subjects. Immediate success abortion occurred in 23 (92%; 95% CI, 81%-100%) of these young women; the remaining subject who aborted did so on study day 10. The single failure was an incomplete abortion. Of the 23 participants who completed the follow-up acceptability evaluation, 4 (17%) believed that the process was a negative experience; 83% of participants would choose this same method again for a future abortion if needed and would recommend this method to a friend. Those who would not try this method again were without support of another individual at the time of the abortion. Conclusions: This medical abortion regimen is effective in adolescents. The overall acceptability in adolescents is similar to that reported for women 18 years of age or older. To minimize the likelihood of a negative experience with this abortion method in adolescents, home support for these patients should be evaluated during pretreatment counseling.

AB - Study Objective: Investigate the potential effectiveness, side effects, and acceptability of medical abortion in female adolescents. Design: Multicenter cohort study. Setting: Magee-Womens Hospital (Pittsburgh, PA) and University of British Columbia (Vancouver, BC, Canada). Participants: Twenty-five pregnant adolescents less than 18 years old up to 49 days' gestation. Interventions: Methotrexate, 50 mg/m2 intramuscularly, followed 5 to 6 days later by misoprostol, 800 μg vaginally, self-administered at home. Misoprostol administration was repeated by a doctor if abortion did not occur within 1 or 2 days. Acceptability was assessed before methotrexate injection and at follow-up 5 weeks later. Main Outcome Measures: Successful abortion (complete abortion without requiring a surgical procedure), immediate success (abortion within 24 hours of initial or repeat misoprostol administration), and acceptability. Results: Complete abortion occurred in 24 of 25 (96%; 95% confidence interval [CI], 88%-100%) subjects. Immediate success abortion occurred in 23 (92%; 95% CI, 81%-100%) of these young women; the remaining subject who aborted did so on study day 10. The single failure was an incomplete abortion. Of the 23 participants who completed the follow-up acceptability evaluation, 4 (17%) believed that the process was a negative experience; 83% of participants would choose this same method again for a future abortion if needed and would recommend this method to a friend. Those who would not try this method again were without support of another individual at the time of the abortion. Conclusions: This medical abortion regimen is effective in adolescents. The overall acceptability in adolescents is similar to that reported for women 18 years of age or older. To minimize the likelihood of a negative experience with this abortion method in adolescents, home support for these patients should be evaluated during pretreatment counseling.

KW - Abortion

KW - Abortion, medical

KW - Methotrexate

KW - Misoprostol

KW - Prostaglandins

UR - http://www.scopus.com/inward/record.url?scp=0033133370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033133370&partnerID=8YFLogxK

U2 - 10.1016/S1083-3188(00)86630-9

DO - 10.1016/S1083-3188(00)86630-9

M3 - Article

C2 - 10326191

AN - SCOPUS:0033133370

VL - 12

SP - 71

EP - 77

JO - Journal of Pediatric and Adolescent Gynecology

JF - Journal of Pediatric and Adolescent Gynecology

SN - 1083-3188

IS - 2

ER -